本文系基于公开资料撰写,仅作为信息交流之用,不构成任何投资建议。美国著名经济学家曼斯菲尔德曾给出这样一条论断:如果没有专利保护,60%的新药不会被发明出来。这句话准确归纳出,现代医药体系建立在专利壁垒之上的行业本质。因此,专利也就成为药企竞争的核心,如百济神州与艾伯维、恒瑞医药与拜耳间,均在近年发生过专利侵权诉讼。6月16日,和铂医药公布了其专利维权行动的最新进展。针对百奥赛图(北京)医药科技股份...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.